Double or triple BNT162b2-vaccinated individuals with a SARS-CoV-2 Omicron BA.1 breakthrough infection exhibited a strongly increased frequency of S glycoprotein-specific BMEM cells, which was higher than those of Omicron-naïve triple-vaccinated individuals (Fig. 3b, d fig. The gene discussed is ART4; the disease is infection.